These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 38389896)

  • 41. Wilson's disease and other neurological copper disorders.
    Bandmann O; Weiss KH; Kaler SG
    Lancet Neurol; 2015 Jan; 14(1):103-13. PubMed ID: 25496901
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The molecular and cellular basis of copper dysregulation and its relationship with human pathologies.
    Maung MT; Carlson A; Olea-Flores M; Elkhadragy L; Schachtschneider KM; Navarro-Tito N; Padilla-Benavides T
    FASEB J; 2021 Sep; 35(9):e21810. PubMed ID: 34390520
    [TBL] [Abstract][Full Text] [Related]  

  • 43. How do thiol disulfide balance and copper-ceruloplasmin levels change in women using copper intrauterine devices?
    Korkmaz H; Deveci CD; Alışık M; Korkmaz V; Kurdoğlu Z; Erel Ö; Üstün Y
    Gynecol Endocrinol; 2022 Aug; 38(8):689-692. PubMed ID: 35758879
    [No Abstract]   [Full Text] [Related]  

  • 44. A low blood copper concentration is a co-morbidity burden factor in Parkinson's disease development.
    Ilyechova EY; Miliukhina IV; Orlov IA; Muruzheva ZM; Puchkova LV; Karpenko MN
    Neurosci Res; 2018 Oct; 135():54-62. PubMed ID: 29203265
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oxidation state-specific fluorescent copper sensors reveal oncogene-driven redox changes that regulate labile copper(II) pools.
    Pezacki AT; Matier CD; Gu X; Kummelstedt E; Bond SE; Torrente L; Jordan-Sciutto KL; DeNicola GM; Su TA; Brady DC; Chang CJ
    Proc Natl Acad Sci U S A; 2022 Oct; 119(43):e2202736119. PubMed ID: 36252013
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New insights into the pathogenesis of copper toxicosis in Wilson's disease: evidence for copper incorporation and defective canalicular transport of caeruloplasmin.
    Chowrimootoo GF; Ahmed HA; Seymour CA
    Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):851-5. PubMed ID: 8645167
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ceruloplasmin in neurodegenerative diseases.
    Vassiliev V; Harris ZL; Zatta P
    Brain Res Brain Res Rev; 2005 Nov; 49(3):633-40. PubMed ID: 16269323
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vivo and in vitro analyses of amygdalar function reveal a role for copper.
    Gaier ED; Rodriguiz RM; Zhou J; Ralle M; Wetsel WC; Eipper BA; Mains RE
    J Neurophysiol; 2014 May; 111(10):1927-39. PubMed ID: 24554785
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis.
    Xu X; Pin S; Gathinji M; Fuchs R; Harris ZL
    Ann N Y Acad Sci; 2004 Mar; 1012():299-305. PubMed ID: 15105274
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum copper, ceruloplasmin and 24-h urine copper evaluations in celiac patients.
    Ince AT; Kayadibi H; Soylu A; Ovunç O; Gültepe M; Toros AB; Yaşar B; Kendir T; Abut E
    Dig Dis Sci; 2008 Jun; 53(6):1564-72. PubMed ID: 17934856
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression profile of the copper homeostasis gene, rAtox1, in the rat brain.
    Naeve GS; Vana AM; Eggold JR; Kelner GS; Maki R; Desouza EB; Foster AC
    Neuroscience; 1999; 93(3):1179-87. PubMed ID: 10473283
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Iron overload and neurodegenerative diseases: What can we learn from
    Martins AC; Virgolini MB; Tinkov AA; Skalny AV; Tirumala RP; Farina M; Santamaria A; Lu R; Aschner M
    Toxicol Res Appl; 2022; 6():. PubMed ID: 35990536
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical utility of copper, ceruloplasmin, and metallothionein plasma determinations in human neurodegenerative patients and their first-degree relatives.
    Arnal N; Cristalli DO; de Alaniz MJ; Marra CA
    Brain Res; 2010 Mar; 1319():118-30. PubMed ID: 20026314
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cerebrospinal fluid diagnostic markers correlate with lower plasma copper and ceruloplasmin in patients with Alzheimer's disease.
    Kessler H; Pajonk FG; Meisser P; Schneider-Axmann T; Hoffmann KH; Supprian T; Herrmann W; Obeid R; Multhaup G; Falkai P; Bayer TA
    J Neural Transm (Vienna); 2006 Nov; 113(11):1763-9. PubMed ID: 16736242
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risks and benefits of copper in light of new insights of copper homeostasis.
    de Romaña DL; Olivares M; Uauy R; Araya M
    J Trace Elem Med Biol; 2011 Jan; 25(1):3-13. PubMed ID: 21342755
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Copper and ceruloplasmin dyshomeostasis in serum and cerebrospinal fluid of multiple sclerosis subjects.
    De Riccardis L; Buccolieri A; Muci M; Pitotti E; De Robertis F; Trianni G; Manno D; Maffia M
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1828-1838. PubMed ID: 29524632
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Loss of OPT3 function decreases phloem copper levels and impairs crosstalk between copper and iron homeostasis and shoot-to-root signaling in Arabidopsis thaliana.
    Chia JC; Yan J; Rahmati Ishka M; Faulkner MM; Simons E; Huang R; Smieska L; Woll A; Tappero R; Kiss A; Jiao C; Fei Z; Kochian LV; Walker E; Piñeros M; Vatamaniuk OK
    Plant Cell; 2023 May; 35(6):2157-2185. PubMed ID: 36814393
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Essential role for mammalian copper transporter Ctr1 in copper homeostasis and embryonic development.
    Lee J; Prohaska JR; Thiele DJ
    Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6842-7. PubMed ID: 11391005
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Redox active metals in neurodegenerative diseases.
    Acevedo K; Masaldan S; Opazo CM; Bush AI
    J Biol Inorg Chem; 2019 Dec; 24(8):1141-1157. PubMed ID: 31650248
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Copper, ceruloplasmin, superoxide dismutase and iron parameters in Parkinson's disease.
    Tórsdóttir G; Kristinsson J; Sveinbjörnsdóttir S; Snaedal J; Jóhannesson T
    Pharmacol Toxicol; 1999 Nov; 85(5):239-43. PubMed ID: 10608487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.